The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms nih 3T3 cells in a MEK-dependent fashion

Cancer Research

Volumn 59, Issue 9, 1999, Pages 2195-2202

  Hartkamp, Jörg ^a   Troppmair, Jakob ^a   Rapp, Ulf R ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MIXED LINEAGE KINASE 3; PROTEIN SERINE THREONINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; ENHANCER REGION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KIDNEY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BINDING SITES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL TRANSFORMATION, NEOPLASTIC; ENHANCER ELEMENTS (GENETICS); ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GENES, REPORTER; MAP KINASE KINASE 1; MAP KINASE KINASE KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 0033135621     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Daum, G., Eisenmann-Tappe, I., Fries, H. W., Troppmair, J., and Rapp, U. R. The ins and outs of Raf kinases. Trends Biochem. Sci., 19: 474-480, 1994.
2. Ip, Y. T., and Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell. Biol., 10: 205-219, 1998.
3. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80: 179-185, 1995.
4. Robinson, M. J., and Cobb, M. H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol., 9: 180-186, 1997.
5. Kyriakis, J. M., and Avruch, J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem., 271: 24313-24316, 1996.
6. Dhanasekaran, N., and Reddy, E. P. Signaling by dual specificity kinases. Oncogene, 17: 1447-1455, 1998.
7. Hill, C. S., and Treisman, R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell, 80: 199-211, 1995.
8. Cowley, S., Paterson, H., Kemp, P., and Marshall, C. J. Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77: 841-852, 1994.
9. Troppmair, J., Bruder, J. T., Munoz, H., Lloyd, P. A., Kyriakis, J., Banerjee, P., Avruch, J., and Rapp, U. R. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-Tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem., 269: 7030-7035, 1994.
10. Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., and Ahn, N. G. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science (Washington DC), 265: 966-970, 1994.
11. Robinson, M. J., Stippec, S. A., Goldsmith, E., White, M. A., and Cobb, M. H. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neunte outgrowth and cell transformation. Curr. Biol., 8: 1141-1150, 1998.
12. Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpera, J. R., Greenberg, M. E., Sawyers, C. E., and Davis, R. J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science (Washington DC), 277: 693-696, 1997.
13. Tanaka, S., Ouchi, T., and Hanafusa, H. Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange factor C3G. Proc. Natl. Acad. Sci. USA, 94: 2356-2361, 1997.
14. Karin, M., Liu, Z-G., and Zandi, E. AP-1 function and regulation. Curr. Opin. Cell. Biol., 9: 240-246, 1997.
15. Whitmarsh, A. J., and Davis, R. J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med., 74: 589-607, 1996.
16. Bos, T. J., Monteclaro, F., Mitsunobu, F., Ball, A. R., Jr., Chang, C. H. W., Nishimura, T., and Vogt, P. K. Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and non-coding sequences. Genes Dev., 4: 1677-1687, 1990.
17. Lloyd, A., Yancheva, N., and Wasylyk, B. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature (Lond.), 352: 635-638, 1991.
18. Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., and Karin, M. Oncogenic and transcriptional cooperation with Ha-ras requires phosphorylation of c-jun on serines 63 and 73. Nature (Lond.), 354: 494-496, 1991.
19. Rapp, U. R., Troppmair, J., Beck, T., and Birrer, M. J. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant. Oncogene, 9: 3493-3498, 1994.
20. Johnson, R., Spiegelman, B., Hanahan, D., and Wisdom, R. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol., 16: 4504-4511, 1996.
21. Hirai, S., Katoh, M., Terada, M., Kyriakis, J. M., Zon, L. I., Rana, A., Avruch, J., and Ohno, S. MST/MLK2, a member of the mixed lineage kinase family, directly phosphorylates and activates SEK1, an activator of c-Jun N-terminal kinase/stress-activated protein kinase. J. Biol. Chem., 272: 15167-15173, 1997.
22. Burbelo, P. D., Drechsel, D., and Hall, A. A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J. Biol. Chem., 270: 29071-29074, 1995.
23. Katoh, M., Hirai, M., Sugimura, T., and Terada, M. Cloning and characterization of MST, a novel (putative) serine/threonine kinase with SH3 domain. Oncogene, 10: 1447-1451, 1995.
24. Ezoe, K., Lee, S-T., Strunk, K. M., and Spritz, R. A. PTK1, a novel protein kinase required for proliferation of human melanocytes. Oncogene, 9: 935-938, 1994.
25. Gallo, K. A., Mark, M. R., Scadden, D. T., Wang, Z., Gu, Q., and Godowski, P. J. Identification and characterization of SPRK, a novel src-homology 3 domain-containing proline-rich kinase with serine/threonine kinase activity. J. Biol. Chem., 269: 15092-15100, 1994.
26. Ing, Y. L., Leung, I. W. L., Heng, H. H. Q., Tsui, L-C., and Lassam, N. J. MLK-3: identification of a widely-expressed protein kinase bearing an SH3 domain and a leucine zipper-basic region domain. Oncogene, 9: 1745-1750, 1994.
27. Rana, A., Gallo, K. A., Godowski, P. J., Hirai, S., Ohno, S., Zon, L., Kyriakis, J. M., and Avruch, J. The mixed lineage kinase SPRK phosphorylates and activates the stress-activated protein kinase activator, SEK-1. J. Biol. Chem., 271: 19025-19028, 1996.
28. Teramoto, H., Coso, O. A., Miyata, H., Igishi, T., Miki, T., and Gutkind, J. S. Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress activated protein kinase pathway. J. Biol. Chem., 277: 27225-27228, 1996.
29. Tibbles, L. A., Ing, Y. L., Kiefer, F., Chan, J., Iscove, N., Woodgett, J. R., and Lassam, N. J. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J., 15: 7026-7035, 1996.
30. Rapp, U. R., and Torada, G. J. Generation of oncogenic type C viruses: rapidly leukemogenic viruses derived from C3H mouse cells in vivo and in vitro. Proc. Natl. Acad. Sci. USA, 75: 2468-2472, 1978.
31. Hoffmeyer, A., Avots, A., Flory, E., Weber, C. K., Serfling, E.. and Rapp, U. R. The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes. J. Biol. Chem., 273: 10112-10119, 1997.
32. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.), 369: 156-160, 1994.
33. Bruder, J. T., Heidecker, G., and Rapp, U. R. Serum-, TPA-, and Ras-induced expression from AP-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev., 6: 545-556, 1992.
34. Morgenstern, J. P., and Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and complementary helper-free packaging cell line. Nucleic Acids Res., 9: 3587-3596, 1990.
35. Whitehurst, C. E., Owaki, H., Bruder, J. T., Rapp, U. R., and Geppert, T. D. The MEK kinase activity of the catalytic domain of RAF-1 is regulated independently of Ras binding in T cells. J. Biol. Chem., 270: 5594-5599, 1995.
36. Heidecker, G., Huleihel, M., Cleveland, J. L., Kolch, W., Beck, T. W., Lloyd, P., Pawson, T., and Rapp, U. R. Mutational activation of c-raf-1 and definition of the minimal transformation sequence. Mol. Cell. Biol., 10: 2503-2512, 1990.
37. Kerkhoff, E., and Rapp, U. R. Induction of cell proliferation in quiescent N1H 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol., 17: 2576-2586, 1997.
38. Chen, C., and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7: 2745-2752, 1987.
39. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
40. Ludwig, S., Engel, K., Hoffmeyer, A., Silhanandam, G., Neufeld, B., Palm, D., Gaestel, M., and Rapp, U. R. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol. Cell. Biol., 16: 6687-6697, 1996.
41. Sanchez, I., Hughes, R. T., Mayer, B. J., Yee, K., Woodgett, J. R., Avruch, J., Kyriakis, J. M., and Zon, L. I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (Lond.), 372: 794-798, 1994.
42. Wasylyk, C., Imler, J. L., and Wasylyk, B. Transforming but not immortalizing oncogenes activate the transcription factor PEA1. EMBO J., 7: 2475-2483, 1988.
43. Treisman, R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell. Biol., 8: 205-215, 1995.
44. Wasylyk, B., Hagman, J., and Gutierrez-Hartmann, A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci., 23: 213-216, 1998.
45. Cavigelli, M., Li, W. W., Lin, A., Su, B., Yoshioka, K., and Karin, M. The tumor promotor arsenite stimulates AP-1 activity by inhibiting a JNK phosphatasc. EMBO J., 15: 6269-6279, 1996.
46. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA, 92: 7686-7689, 1995.
47. Dérijard, B., Hibi, M., Wu, I., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. JNK1: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylales the c-Jun activation domain. Cell, 76: 1025-1037, 1994.
48. Minden, A., Lin, A., Smeal, T., Derijard, B., Cobb, M., Davis, R. J., and Karin, M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol., 14: 6683-6688, 1994.
49. Leppä, S., Saffrich, R., Ansorge, W., and Bohmann, D. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J., 17: 4404-4413, 1998.
50. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A., and Trzaskos, J. M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem., 273: 18623-18632, 1998.
51. Hagemann, D., Troppmair, J., and Rapp. U. R. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells. Oncogene, in press, 1999.
52. raf-1. EMBO J., 13: 1610-1619, 1994.
53. Salmerón, A., Ahmad, T. B., Carlife, G. W., Pappin, D., Narsimhan, R. P., and Ley, S. C. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J., 15: 817-826, 1996.
54. Lange-Carter, C. A., Pleiman, C. M., Gardner, A. M., Blumer, K. J., and Johnson, G. L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science (Washington DC), 260: 315-319, 1993.
55. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Dérijard, B., Davis, R. J., Johnson, G. L., and Karin, M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (Washington DC), 266: 1719-1723, 1994.
56. Xu, S., Robbins, D., Frost, J., Dang, A., Lange-Carter, C., and Cobb, M. H. MEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA, 92: 6808-6812, 1995.
57. Gopalbhai, K., and Meloche, S. Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in Rat fibroblasts transformed by upstream oncoproteins. J. Cell. Physiol., 174: 35-47, 1998.